{"id":"W4383186570","doi":"10.18553/jmcp.2023.29.7.758","title":"Health-related quality of life in GALAHAD: A multicenter, open-label, phase 2 study of niraparib for patients with metastatic castration-resistant prostate cancer and DNA-repair gene defects","year":2023,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; University of British Columbia; BC Cancer Agency","funders":"National Cancer Institute","keywords":"Medicine; Prostate cancer; Oncology; Internal medicine; Olaparib; Cohort; Taxane; Breast cancer; Cancer; Poly ADP ribose polymerase; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001875627,0.0013893,0.001673526,0.0003945436,0.000418748,0.001012757,0.0009931671,0.001066426,0.002705736],"category_scores_gemma":[0.001107227,0.0005642709,0.001906339,0.0004302521,0.0009972084,0.0007422713,0.0004977171,0.002761373,0.0004739196],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007329726,"about_ca_system_score_gemma":0.001215236,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006657303,"about_ca_topic_score_gemma":0.001267252,"domain_scores_codex":[0.9991861,0.0004699687,0.00002439764,0.0001496078,0.00007409982,0.0000958061],"domain_scores_gemma":[0.9992223,0.0001038519,0.0001467969,0.00007310102,0.0000610244,0.0003929848],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.77737,0.1106283,0.0152497,0.0006562628,0.002211585,0.0001941458,0.0002866811,0.001459101,0.01926433,0.0001745772,0.002696501,0.06980879],"study_design_scores_gemma":[0.7248711,0.2491864,0.02258467,0.00001876764,0.0003796695,0.0001828214,0.00004806233,0.0009093576,0.0006803249,0.0001096762,0.000998389,0.00003072925],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995948,0.0009487132,0.0002886249,0.0003794851,0.00008821976,0.001033948,0.0006586986,0.00004618716,0.0006081553],"genre_scores_gemma":[0.9926428,0.0007662433,0.001234137,0.001001989,0.0001610521,0.001875761,0.001522981,0.00001394318,0.0007811057],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002705736,"threshold_uncertainty_score":0.009919345,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09824664513683765,"score_gpt":0.4361366479699835,"score_spread":0.3378900028331459,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}